New Benefits by Medicare

Turn on more accessible mode

Turn off more accessible mode

Skip Ribbon Commands

Skip to main content

Turn off Animations

Turn on Animations

New Benefits by Medicare

Stay healthy, there are changes in benefits covered by Medicare

At MCS Classicare, we keep you informed to help you stay healthy. In this section, we inform you about the new benefits or changes that the Medicare and Medicaid Service Centers (CMS) have made to the Medicare Program that also apply to your Medicare Advantage Plan.

If you click any of the following links, you could be leaving the MCS Classicare Website and be directed to the CMS.gov Website

https://www.cms.gov/medicare-coverage-database/new-search/reports/national-coverage-ncd-report.aspx

New Benefits

Seat Elevation Equipment (Power Operated) on Power Wheelchairs

Beta Amyloid Positron Tomography in Dementia and Neurodegenerative Disease - Update: 12/18/2023

Cochlear Implantation - Updated 10/17/2022

Home Use of Oxygen - Updated 10/11/2022

Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease - Update: 05/06/2022

Screening for Lung Cancer with Low Dose Computed Tomography (LCDT) - Update: 03/03/2022

Transvenous (Catheter) Pulmonary Embolectomy - Update: 11/18/2021

Use of oxygen at home to treat cluster headaches - Update: 10/19/2021

National Coverage Determination for Chimeric Antigen Receptor (CAR) T-cell Therapy - Update: 07/08/2021

National Coverage Determination for Colorectal Cancer Screening Tests - Blood-Based Biomarker Tests (CAG-00454N) - Update: 07/08/2021

Decision Memo for Autologous Blood-Derived Products for Chronic Non-Healing Wounds (CAG-00190R4) - Update: 07/08/2021

Transcatheter Aortic Valve Replacement (TAVR) - Update: 4/29/2020

Next Generation Sequencing (NGS) for Medicare Beneficiaries with Advanced Cancer (CAG-00450R)

Chimeric Antigen Receptor (CAR) T-cell Therapy for Cancers (CAG-00451N)

National Coverage Determination (NCD) for Acupuncture for Chronic Low Back Pain (CAG-00452N)

National Coverage Determination (NCD) for Cardiac Rehabilitation Programs for Chronic Heart Failure (20.10.1)

Decision Memo for Screening for the HIV Infection (CAG-00409R)

Screening for Lung Cancer with Low Dose Computed Tomography (LCDT)(CAG-00439N)

Microvolt T-wave Alternans (CAG-00293R2)

National Coverage Determination (NCD) for Transcatheter Mitral Valve Repair (TMVR) (20.33)

National Coverage Determination (NCD) for Colorectal Cancer Screening Tests (210.3)

National Coverage Determination (NCD) for Intensive Cardiac Rehabilitation Program-Benson-Henry Institute Cardiac Wellness Program (20.31.3)

Screening for Colorectal Cancer - Stool DNA Testing (CAG-00440N)

National Coverage Determination (NCD) for Screening for Hepatitis C Virus (HCV) in Adults (210.13)

National Coverage Determination (NCD) for Ventricular Assist Devices (20.9.1)

National Coverage Determination (NCD) for Artificial Hearts and Related Devices (20.9)

Transcatheter Mitral Valve Repair (TMVR) (CAG-00438N)

Screening for Hepatitis C Virus (HCV) in Adults (CAG-00436N)

Intensive Cardiac Rehabilitation (ICR) Program - Benson-Henry Institute Cardiac Wellness Program (CAG-00434N)

National Coverage Determination (NCD) for Cardiac Pacemakers: Single-Chamber and Dual-Chamber Permanent Cardiac Pacemakers (20.8.3)

Ventricular Assist Devices for Bridge to Transplant Destination Therapy (CAG-00432R)

Beta Amyloid Positron Tomography in Dementia and Neurodegenerative Disease (220.6.20)

Cardiac Rehabilitation (CR) Programs-Chronic Heart Failure (CAG-00437N)

National Coverage Determination (NCD) for Aprepitant for Chemotherapy-Induced Emesis (110.18)

National Coverage Determination (NCD) for Positron Emission Tomography (FDG) for Oncologic Conditions (220.6.17)

National Coverage Determination (NCD) for Cardiac Pacemakers (20.8)

Decision Memo for Positron Emission Tomography (NaF-18)to Identify Bone Metastasis of Cancer (CAG-00065R2)

Decision Memo for Stem Cell Transplantation (Multiple Myeloma, Myelofibrosis, and Sickle Cell Disease) (CAG-00444R)

Decision Memo for Percutaneous Left Atrial Appendage (LAA) Closure Therapy (CAG-00445N)

Decision Memo for Gender Dysphoria and Gender Reassignment Surgery (CAG-00446N)

National Coverage Determination (NCD) for Screening for Cervical Cancer with Human Papillomavirus (HPV) (210.2.1)

National Coverage Determination (NCD) for Percutaneous Left Atrial Appendage Closure (LAAC)(20.34)

National Coverage Determination (NCD) for Screening for the Human Immunodeficiency Virus (HIV) Infection (210.7)

National Coverage Determination (NCD) for Stem Cell Transplantation Formerly 110.8.1 (110.23)

National Coverage Determination (NCD) for Screening for Hepatitis B Virus (HBV) Infection (210.6)

National Coverage Determination (NCD) for Leadless Pacemakers (20.8.4)

National Coverage Determination (NCD) for Gender Dysphoria and Gender Reassignment Surgery (140.9)

National Coverage Determination (NCD) for Percutaneous image-guided lumbar decompression for lumbar spinal stenosis (150.13)

National Coverage Determination (NCD) for Counseling to Prevent Tobacco Use (210.4.1)

NCD National Coverage Determination (NCD) for Hyperbaric Oxygen Therapy (20.29)

Decision Memo for Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD) (CAG-00449N)

National Coverage Determination (NCD) for Magnetic Resonance Imaging (220.2)

NCD for Implantable Automatic Defibrillators (20.4)

NCD for Next Generation Sequencing (NGS) (90.2)

Decision Memo for Vagus Nerve Stimulation (VNS) for Treatment Resistant Depression (TRD) (CAG-00313R2)

Decision Memo for Transcatheter Aortic Valve Replacement (TAVR) (CAG-00430R)

Decision Memo for Ambulatory Blood Pressure Monitoring (ABPM) (CAG-00067R2)

Stay healthy, there are changes in benefits covered by Medicare

At MCS Classicare, we keep you informed to help you stay healthy. In this section, we inform you about the new benefits or changes that the Medicare and Medicaid Service Centers (CMS) have made to the Medicare Program that also apply to your Medicare Advantage Plan.

If you click any of the following links, you could be leaving the MCS Classicare Website and be directed to the CMS.gov Website

Changed Benefits

National Coverage Determination (NCD) for Carotid Sinus Nerve Stimulator-RETIRED (160.6)

National Coverage Determination (NCD) for Electron Microscope-RETIRED (190.4)

National Coverage Determination (NCD) for Electronecephalographic (EEG) Monitoring During Open-Heart Surgery-RETIRED (160.9)

National Coverage Determination (NCD) for Nuclear Radiology Procedure-RETIRED (220.8)

National Coverage Determination (NCD) for Stereotactic Cingulotomy as a Means of Psychosurgery-RETIRED (160.4)

National Coverage Determination (NCD) for Tinnitus Masking-RETIRED (50.6)

National Coverage Determination (NCD) for Xenon Scan-RETIRED (220.7)

National Coverage Determination (NCD) for Smoking and Tobacco-Use Cessation Counseling - RETIRED (210.4)